Jingyuan S. Wan

Chongqing, 400016, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Rutin attenuates liver fibrosis via the IRG1-itaconate-Nrf2 axis.

Rutin attenuates liver fibrosis via the IRG1-itaconate-Nrf2 axis.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: February 22, 2026

Glycolysis drives vascular hyperpermeability in acute lung injury via lactate-GPR81 axis in endothelial cells.

Glycolysis drives vascular hyperpermeability in acute lung injury via lactate-GPR81 axis in endothelial cells.

Journal: Cell communication and signaling : CCS

Published: September 02, 2025

Macrophage ALDH2 drives immunotherapy resistance by silencing CXCL9 through metabolic-epigenetic crosstalk.

Macrophage ALDH2 drives immunotherapy resistance by silencing CXCL9 through metabolic-epigenetic crosstalk.

Journal: Nature communications

Published: August 11, 2025

Macrophage-derived DLL4 promotes liver fibrosis by activating the Notch pathway in hepatic stellate cells.

Macrophage-derived DLL4 promotes liver fibrosis by activating the Notch pathway in hepatic stellate cells.

Journal: Free radical biology & medicine

Published: June 29, 2025

PROM2 exacerbates CCl4-Induced liver fibrosis via NLRP3 inflammasome activation and hepatocyte pyroptosis.

PROM2 exacerbates CCl4-Induced liver fibrosis via NLRP3 inflammasome activation and hepatocyte pyroptosis.

Journal: Cellular and molecular life sciences : CMLS

Published: May 18, 2025

Dihydrotanshinone I Attenuates Diet-Induced Nonalcoholic Fatty Liver Disease via Up-Regulation of IRG1.

Dihydrotanshinone I Attenuates Diet-Induced Nonalcoholic Fatty Liver Disease via Up-Regulation of IRG1.

Journal: Phytotherapy research : PTR

Published: September 12, 2024

AEBP1 drives fibroblast-mediated T cell dysfunction in tumors.

AEBP1 drives fibroblast-mediated T cell dysfunction in tumors.

Journal: Nature communications

Published: August 22, 2024

Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy.

Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy.

Journal: The Journal of clinical investigation

Published: May 29, 2024

Ginkgolide C attenuated Western diet-induced non-alcoholic fatty liver disease via increasing AMPK activation.

Ginkgolide C attenuated Western diet-induced non-alcoholic fatty liver disease via increasing AMPK activation.

Journal: Inflammation

Published: March 22, 2024

Derlin-1 promotes diet-induced non-alcoholic fatty liver disease via increasing RIPK3-mediated necroptosis.

Derlin-1 promotes diet-induced non-alcoholic fatty liver disease via increasing RIPK3-mediated necroptosis.

Journal: Free radical biology & medicine

Published: January 08, 2024

LXA4 protected mice from renal ischemia/reperfusion injury by promoting IRG1/Nrf2 and IRAK-M-TRAF6 signal pathways.

LXA4 protected mice from renal ischemia/reperfusion injury by promoting IRG1/Nrf2 and IRAK-M-TRAF6 signal pathways.

Journal: Clinical immunology (Orlando, Fla.)

Published: September 24, 2023

Protectin D1 inhibits TLR4 signaling pathway to alleviate non-alcoholic steatohepatitis via upregulating IRAK-M.

Protectin D1 inhibits TLR4 signaling pathway to alleviate non-alcoholic steatohepatitis via upregulating IRAK-M.

Journal: Free radical biology & medicine

Published: September 20, 2023

Showing 1-12 of 88

Last Updated: 09/26/2026